These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35690314)

  • 21. Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
    Cheng A; Zhang Y; Blasco-Colmenares E; Dalal D; Butcher B; Norgard S; Eldadah Z; Ellenbogen KA; Dickfeld T; Spragg DD; Marine JE; Guallar E; Tomaselli GF
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1084-91. PubMed ID: 25273351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.
    Chia PL; Foo D
    Singapore Med J; 2016 Jul; 57(7):354-9. PubMed ID: 27440409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of COVID-19 Pandemic on Physical Activity in Patients With Implantable Cardioverter-Defibrillators.
    Sassone B; Mandini S; Grazzi G; Mazzoni G; Myers J; Pasanisi G
    J Cardiopulm Rehabil Prev; 2020 Sep; 40(5):285-286. PubMed ID: 32804796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V; Perault R; Bories MC; Narayanan K; Garcia R; Combes N; Perier MC; Defaye P; Sadoul N; Gras D; Klug D; Bordachar P; Fauchier L; Deharo JC; Leclercq C; Boveda S; Marijon E; Babuty D;
    Arch Cardiovasc Dis; 2018 Dec; 111(12):758-765. PubMed ID: 30078651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electrical treatment in heart failure].
    Leclercq C; Mabo P; Daubert C
    Rev Prat; 2010 Sep; 60(7):947-50. PubMed ID: 21033492
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic significance of implantable defibrillator shock: are all shocks created equal?
    Freedberg NA; Feldman A
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):741-3. PubMed ID: 22494054
    [No Abstract]   [Full Text] [Related]  

  • 29. Telemedical Concepts for Heart Failure Patients Treated with a Wearable Cardioverter Defibrillator.
    Reiss N; Schmidt T; Hoffmann JD; Kunzendorf S; Luegmair G; Tröger T; Buj C; Müller-von Aschwege F
    Stud Health Technol Inform; 2020 Jun; 271():93-100. PubMed ID: 32578547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health status measured by Kansas City Cardiomyopathy Questionnaire-12 in primary prevention implantable cardioverter defibrillator patients with heart failure.
    Mattsson G; Wallhagen M; Magnusson P
    BMC Cardiovasc Disord; 2021 Aug; 21(1):411. PubMed ID: 34454427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Older Heart Failure Patients With Diabetes Mellitus.
    Sharma A; Wu J; Xu H; Hernandez A; Felker GM; Al-Khatib S; Green J; Matsouaka R; Fonarow GC; Singh JP; Heidenreich PA; Ezekowitz JA; DeVore A
    J Am Heart Assoc; 2020 Jun; 9(12):e012405. PubMed ID: 32476539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tackling postoperative sudden cardiac death in high-risk cardiac surgical patients-role of wearable cardioverter defibrillators.
    Starck C; Kaemmel J; Falk V
    Eur J Cardiothorac Surg; 2022 May; 61(5):1041-1042. PubMed ID: 35165712
    [No Abstract]   [Full Text] [Related]  

  • 33. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single chamber implantable cardioverter defibrillator compared to dual chamber implantable cardioverter defibrillator: less is more! Data from the German Device Registry.
    Bogossian H; Frommeyer G; Hochadel M; Ince H; Spitzer SG; Eckardt L; Maier SKG; Kleemann T; Brachmann J; Stellbrink C; Gonska BD; Kääb S; Senges J; Lemke B
    Clin Res Cardiol; 2020 Jul; 109(7):911-917. PubMed ID: 31823040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of implantable cardioverter-defibrillators in patients with continuous flow ventricular assist devices.
    Boilson BA; Friedman PA
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):663-5. PubMed ID: 23962858
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiac Implantable Electronic Device Therapy in Heart Failure.
    Hussein AA; Wilkoff BL
    Circ Res; 2019 May; 124(11):1584-1597. PubMed ID: 31120815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S; Rosenkaimer SL; Hohneck A; Lang S; El-Battrawy I; Rudic B; Tülümen E; Stach K; Kuschyk J; Akin I; Borggrefe M
    BMC Cardiovasc Disord; 2018 Mar; 18(1):52. PubMed ID: 29544442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The implantable cardioverter-defibrillator: An update.
    Miller JD; Yousuf O; Berger RD
    Trends Cardiovasc Med; 2015 Oct; 25(7):606-11. PubMed ID: 25912255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Important Parameters for Implantable Cardioverter Defibrillator Selection.
    Zungsontiporn N; Loguidice M; Daniels J
    Card Electrophysiol Clin; 2018 Mar; 10(1):145-152. PubMed ID: 29428136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.